Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies

被引:163
作者
Pan, Yu [1 ,2 ]
Cai, Wenpeng [1 ]
Cheng, Qi [3 ]
Dong, Wei [1 ]
An, Ting [4 ]
Yan, Jin [1 ]
机构
[1] Second Mil Med Univ, Dept Psychol & Mental Hlth, Shanghai 200433, Peoples R China
[2] Peoples Liberat Army Gen Hosp, Dept Psychol, Beijing, Peoples R China
[3] 102 Hosp PLA, Dept Child & Adolescent Behav Med, Changzhou, Peoples R China
[4] PLA Second Artillery Force Gen Hosp, Dept Internal Med, Beijing, Peoples R China
关键词
human; epidemiological association; anxiety disorder; hypertension; meta-analysis; AUTONOMIC NERVOUS-SYSTEM; BLOOD-PRESSURE; ENDOTHELIAL FUNCTION; GENERAL-POPULATION; METABOLIC SYNDROME; MENTAL-DISORDERS; ANGIOTENSIN-II; FOLLOW-UP; DEPRESSION; RISK;
D O I
10.2147/NDT.S77710
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Epidemiological studies have repeatedly investigated the association between anxiety and hypertension. However, the results have been inconsistent. This study aimed to summarize the current evidence from cross-sectional and prospective studies that evaluated this association. Methods: Seven common databases were searched for articles published up to November 2014. Cross-sectional and prospective studies that reported an association between the two conditions in adults were included. Data on prevalence, incidence, unadjusted or adjusted odds ratios or hazard ratios, and 95% confidence intervals (CIs) were extracted or calculated by the authors. The pooled odds ratio was calculated separately for cross-sectional and prospective studies using random-effects models. The Q test and I-2 statistic was used to assess heterogeneity. A funnel plot and modified Egger linear regression test were used to estimate publication bias. Results: The search yielded 13 cross-sectional studies (n=151,389), and the final pooled odds ratio was 1.18 (95% CI 1.02-1.37; P-Q<0.001; I-2=84.9%). Eight prospective studies with a total sample size of 80,146 and 2,394 hypertension case subjects, and the pooled adjusted hazard ratio was 1.55 (95% CI 1.24-1.94; P-Q<0.001; I-2=84.6%). The meta-regression showed that location, diagnostic criteria for anxiety, age, sex, sample size, year of publication, quality, and years of follow-up (for prospective study) were not sources of heterogeneity. Conclusion: Our results suggest that there is an association between anxiety and increased risk of hypertension. These results support early detection and management of anxiety in hypertensive patients.
引用
收藏
页码:1121 / 1130
页数:10
相关论文
共 66 条
[1]  
[Anonymous], J HUM HYPERTENS
[2]  
[Anonymous], 2008, Global Health Risks Mortality and burden of disease attributable to selected major risks
[3]  
[Anonymous], CHINESE J HYPERTENSI
[4]  
[Anonymous], J HLTH PSYCHOL
[5]   The Impact of Mood and Anxiety Disorders on Incident Hypertension at One Year [J].
Bacon, Simon L. ;
Campbell, Tavis S. ;
Arsenault, Andre ;
Lavoie, Kim L. .
INTERNATIONAL JOURNAL OF HYPERTENSION, 2014, 2014
[6]   Anxiety, depression and autonomic nervous system dysfunction in hypertension [J].
Bajko, Zoltan ;
Szekeres, Csilla-Cecilia ;
Kovacs, Katalin Reka ;
Csapo, Krisztina ;
Molnar, Sandor ;
Soltesz, Pal ;
Nyitrai, Erika ;
Magyar, Maria Tuende ;
Olah, Laszlo ;
Bereczki, Daniel ;
Csiba, Laszlo .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 317 (1-2) :112-116
[7]   Symptoms of Depression and Anxiety and Adherence to Antihypertensive Medication [J].
Bautista, Leonelo E. ;
Vera-Cala, Lina M. ;
Colombo, Cynthia ;
Smith, Paul .
AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (04) :505-511
[8]   Chronic work stress and exhaustion is associated with higher allostastic load in female school teachers [J].
Bellingrath, Silja ;
Weigl, Tobias ;
Kudielka, Brigitte M. .
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 2009, 12 (01) :37-48
[9]   Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease [J].
Bonnet, F ;
Irving, K ;
Terra, JL ;
Nony, P ;
Berthezène, F ;
Moulin, P .
ATHEROSCLEROSIS, 2005, 178 (02) :339-344
[10]  
Braszko JJ, 2003, J PHYSIOL PHARMACOL, V54, P271